Health and Healthcare
1240 Articles
Two of the best-selling drugs in the US are Procrit from Johnson & Johnson (NYSE: JNJ) and Aranesp from Amgen…
According to Reuters, weak confidence and rising prices are fuelin stagflation fears. Reuters writes that the long fight between Microsoft…
These are the new combined holdings (alphabetically H-P) from Warren Buffett’s Berkshire Hathaway (NYSE: BRK-A) for the period ended December…
Medtronic, Inc. (NYSE: MDT) has just announced that it has received formal approval from the FDA to market its Endeavor…
Below is a list of Dow Jones Industrial Average components that are actually down the least on an ugly day. …
Johnson & Johnson (JNJ) announced record sales of $16.0 billion for the fourth quarter of 2007, an increase of 16.6%…
Of the earnings that will hit over the next week, none are as important as Microsoft (MSFT) and AT&T (T).…
Monday is a market holiday in observance of Martin Luther King Day in the U.S. But after that we have…
These are not the only top analyst calls impacting share prices this morning, but these are the main calls that…
We are updating our list of tier-one Defensive Stocks since so many of these stocks have run up and since…
Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks…
James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad…
According to Reuters, OPEC will probably keep oil output at current levels. Reuters writes that a goverment plan to help…
Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness…
Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX)…
Our top personal finance-related articles today. Your wallet will thank you later.